Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 4 Current proposed guidelines for starting enzyme replacement therapy in Fabry disease patients

From: Fabry disease

Subpopulation Guidelines for onset of ERT
Adult males (over 16 years) At time of diagnosis of Fabry disease
Boys At time of development of significant symptoms or if asymptomatic, consider at 7-10 years
Females (all ages) Symptoms or evidence of progression of organ involvement
  1. Note: the recommendations are proposed guidelines from an international panel of physicians with expertise in Fabry disease [51]. They are currently not followed in every country and may be revised when additional studies on the outcome of the safety and efficacy of enzyme replacement therapy become available.